Reaction
Appendix Disorder reporting signals
As of the last recalculation, Appendix Disorder appears in 1,398 FAERS reports alongside 16 co-occurring drug terms. The strongest observed disproportionality signal is ALENDRONATE SODIUM (PRR 24.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Alendronate Sodium | 147 | 24.1 | 24.2 |
| Naproxen Sodium Tablet, Coated | 15 | 16.7 | 16.7 |
| Naproxen Sodium, Coated Tablets | 15 | 16.7 | 16.7 |
| Naproxen Sodium 220Mg | 15 | 16.6 | 16.7 |
| Infliximab-Dyyb | 22 | 11.4 | 11.4 |
| Lifitegrast | 9 | 8.2 | 8.3 |
| Lumacaftor And Ivacaftor | 4 | 7.0 | 7.0 |
| Etonogestrel And Ethinyl Estradiol | 10 | 6.8 | 6.8 |
| Agalsidase Beta | 4 | 6.5 | 6.5 |
| Buprenorphine Hydrochloride, Naloxone Hydrochloride | 10 | 6.2 | 6.2 |
| Cabozantinib | 12 | 3.7 | 3.7 |
| Orlistat | 6 | 3.5 | 3.5 |
| Pomalidomide | 22 | 3.2 | 3.2 |
| Somatropin | 15 | 3.1 | 3.1 |
| Bimekizumab | 4 | 2.8 | 2.8 |
| Voxelotor | 3 | 2.0 | 2.0 |